Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination nutraceutical product consists of glucosamine sulfate, chondroitin sulfate, and methylsulfonylmethane (MSM). It is primarily used as a dietary supplement to support joint health and manage symptoms of osteoarthritis. Glucosamine and chondroitin are structural components of cartilage that promote the synthesis of the cartilage matrix while inhibiting degradative enzymes. MSM provides a source of organic sulfur and exerts anti-inflammatory and antioxidant effects. The University of Guadalajara has investigated this combination in clinical trials, including its potential role in managing secondary osteoporosis in specific populations, such as men with HIV, often as an adjunct to antiresorptive therapies like zoledronic acid. While some formulations under the brand name Colaren used in these trials may vary in composition (sometimes containing calcium and vitamin D), the glucosamine/chondroitin/MSM version is a recognized formulation studied by the institution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate + chondroitin sulfate + methylsulfonylmethane.